Has a 3-fold Decreased Dose of Bacillus Calmette-guerin the Same Efficacy Against Recurrences and Progression of T1g3 and Tis Bladder Tumors Than the Standard Dose? Results of a Prospective Randomized Trial
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Urology
Authors: JOSÉ A. MARTÍNEZ-PIÑEIRO, LUIS MARTÍNEZ-PIÑEIRO, EDUARDO SOLSONA, RAFAEL HERNÁNDEZ RODRÍGUEZ, JESÚS MARÍA FERNÁNDEZ GÓMEZ, MARCELINO GONZÁLEZ MARTÍN, JESÚS RODRÍGUEZ MOLINA, ANABEL GIMENO COLLADO, NICOLÁS FLORES, SANTIAGO ISORNA, CARLOS PERTUSA, MARIANO RABADÁN, ANDER ASTOBIETA, JOSÉ EMILIO CAMACHO, SALVADOR ARRIBAS, ROSARIO MADERO, For CLUB UROLÓGICO ESPAÑOL de TRATAMIENTO ONCOLÓGICO (CUETO)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1993844636
